a syndicate of new

Syndicate Bio is a platform-based biotechnology company focused on driving genomics-led drug discovery and development for diverse global populations, with a primary focus on the African continent. By establishing strategic partnerships with governments, academia, and pharmaceutical companies, the company aims to bridge the gap in genomic data representation. Syndicate Bio leverages large-scale genomic datasets to identify novel therapeutic targets and biomarkers across various disease areas, including oncology and infectious diseases. Their business model centers on ethical data sourcing and collaborative research to accelerate the delivery of precision medicine to underserved regions.